Insider Trading June 16, 2026 06:22 PM

Globe Life Executive Dolores Skarjune Executes $693K Stock Sale Following Strong Rally

EVP and CAO exercises options while selling shares near 52-week highs as analysts adjust price targets

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
GL

Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer at Globe Life Inc. (NASDAQ: GL), has reported a series of transactions involving the company's common stock on June 12, 2026. The executive executed a combined strategy of selling a portion of her holdings and exercising employee stock options, reflecting complex insider activity as the stock trades near its peak valuations.

Globe Life Executive Dolores Skarjune Executes $693K Stock Sale Following Strong Rally
GL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Globe Life stock has experienced a 41% gain over the past year, trading near its 52-week high of $170.11.
  • Analysts from Raymond James, BMO Capital, and Truist Securities have raised price targets, citing strong cash flow and EPS estimates.
  • Executive Dolores Skarjune sold 4,175 shares near the top of the trading range while exercising options to acquire an equal number of shares.

MCKINNEY, TX – Dolores L. Skarjune, serving as Executive Vice President and Chief Administrative Officer at Globe Life Inc. (NASDAQ: GL), has disclosed recent transaction activity concerning the company's common equity. On June 12, 2026, Skarjune executed a sequence of sales totaling approximately $693,794 while simultaneously acquiring shares through the exercise of stock options valued at roughly $418,833.

The sales activity involved the disposition of 4,175 shares of Globe Life common stock. These transactions were executed at varying price points, ranging from $165.5846 to $167.253 per share. The specific breakdown of the sales includes 2,198 shares sold at prices between $165.17 and $166.105 per share, 1,103 shares sold at prices between $166.115 and $166.99 per share, and 874 shares sold at prices between $167.155 and $167.445 per share.

This timing of the sales is particularly notable given the current market positioning of Globe Life stock. The shares are currently trading at $169.17, a level just 1% below its 52-week high of $170.11. This price action follows a substantial 41% gain recorded over the past year. According to analysis by InvestingPro, the stock appears to be overvalued relative to its calculated Fair Value, a classification that places Globe Life among companies listed on the Most Overvalued list. For investors seeking deeper insights, Globe Life's comprehensive Pro Research Report is available, providing actionable intelligence derived from complex data transformations across 1,400+ reports.

Concurrently with the sales, Ms. Skarjune acquired 4,175 shares of common stock through the exercise of employee stock options. These acquisitions were executed at prices ranging from $98.32 to $103.23 per share. The specific acquisitions included 2,475 shares acquired at an exercise price of $98.32 and 1,700 shares acquired at an exercise price of $103.23.

Following these transactions, Ms. Skarjune's direct ownership of Globe Life common stock stands at 13,696.734 shares. This direct holding comprises 5.0088 dividend equivalent restricted stock units and 12.9066 shares acquired through the company's dividend reinvestment plan since the date of the last report. Additionally, she maintains indirect ownership of 2,894.735 shares through a 401(K) Plan.

In other recent developments, Globe Life Inc. reported its first-quarter 2026 earnings. The company revealed an earnings per share (EPS) of $3.43, which fell slightly below the anticipated $3.48, resulting in a 1.44% negative surprise. However, revenue aligned with expectations at $1.56 billion. Despite the earnings miss, multiple analysts have adjusted their outlooks for the company. Raymond James raised its price target for Globe Life to $208 from $188, maintaining a Strong Buy rating, citing the company's strong cash flow generation as a key factor. Similarly, BMO Capital increased its price target to $150 from $148, reflecting an estimated 6.5% free cash flow yield for 2026. Truist Securities also raised its price target to $185 from $180 while maintaining a Buy rating, noting an increase in its 2026 EPS estimate to $15.60 from $15.30.

Risks

  • InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value, placing it on the Most Overvalued list.
  • The company reported a 1.44% negative surprise in first-quarter EPS, falling short of anticipated earnings.
  • The divergence between strong analyst price targets and recent earnings misses highlights uncertainty in valuation expectations.

More from Insider Trading

Nexstar CFO Lee Ann Gliha Offloads Shares to Cover RSU Tax Obligations Jun 16, 2026 EchoStar Executive Dean Manson Executes $1.3 Million Stock Sale Under Pre-Arranged Plan Jun 16, 2026 Basswood Capital Trims Dime Community Bancshares Position Amid Valuation Concerns Jun 16, 2026 Netskope Director Arif Janmohamed Offloads $15.1 Million in Class A Shares Jun 16, 2026 Lightspeed Opportunity Fund Offloads $15.1 Million in Netskope Shares Amid Market Valuation Shifts Jun 16, 2026